Hans-Joachim Gabius Selected Research

Galectins (Galectin)

2/2022	Galectin network in osteoarthritis: galectin-4 programs a pathogenic signature of gene and effector expression in human chondrocytes in vitro.
12/2021	The marriage of chemokines and galectins as functional heterodimers.
1/2021	N-Glycan profiling of chondrocytes and fibroblast-like synoviocytes: Towards functional glycomics in osteoarthritis.
1/2021	Human galectin‑3: Molecular switch of gene expression in dermal fibroblasts in vitro and of skin collagen organization in open wounds and tensile strength in incisions in vivo.
4/2020	The emerging role of galectins in (re)myelination and its potential for developing new approaches to treat multiple sclerosis.
1/2020	Chemokines and galectins form heterodimers to modulate inflammation.
10/2019	Galectins-1 and -3 in Human Intervertebral Disc Degeneration: Non-Uniform Distribution Profiles and Activation of Disease Markers Involving NF-κB by Galectin-1.
11/2018	Galectin-8 induces functional disease markers in human osteoarthritis and cooperates with galectins-1 and -3.
12/2017	Analyzing epigenetic control of galectin expression indicates silencing of galectin-12 by promoter methylation in colorectal cancer.
10/2017	Combination of galectin-3, CK19 and HBME-1 immunostaining improves the diagnosis of thyroid cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hans-Joachim Gabius Research Topics

Disease

86	Neoplasms (Cancer) 01/2021 - 01/2002
17	Carcinoma (Carcinomatosis) 09/2017 - 12/2002
12	Squamous Cell Carcinoma (Epidermoid Carcinoma) 07/2014 - 03/2002
10	Neuroblastoma 01/2020 - 01/2002
10	Colonic Neoplasms (Colon Cancer) 01/2019 - 06/2003
7	Osteoarthritis 02/2022 - 10/2014
7	Inflammation (Inflammations) 12/2021 - 06/2004
7	Squamous Cell Carcinoma of Head and Neck 03/2018 - 01/2003
6	Disease Progression 02/2022 - 08/2004
5	Wounds and Injuries (Trauma) 01/2021 - 01/2011
5	Colorectal Neoplasms (Colorectal Cancer) 01/2019 - 01/2003
5	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018 - 07/2007
5	Carcinogenesis 08/2014 - 01/2005
4	Infections 01/2021 - 06/2004
4	Lymphatic Metastasis 08/2013 - 01/2003
4	Nasal Polyps (Nasal Polyp) 07/2004 - 02/2002
3	Virus Diseases (Viral Diseases) 01/2021 - 12/2010
3	Adenocarcinoma 01/2018 - 01/2005
3	Thyroid Neoplasms (Thyroid Cancer) 10/2017 - 07/2008
3	Adenoma (Adenomas) 10/2017 - 12/2002
3	Breast Neoplasms (Breast Cancer) 08/2014 - 07/2007
3	Hypopharyngeal Neoplasms 02/2009 - 07/2006
3	Laryngeal Neoplasms (Laryngeal Cancer) 01/2009 - 05/2007
3	Basal Cell Carcinoma (Rodent Ulcer) 11/2006 - 01/2002
3	Neoplasm Metastasis (Metastasis) 08/2006 - 05/2003
3	Craniopharyngioma (Craniopharyngiomas) 04/2005 - 03/2002
2	Multiple Sclerosis 04/2020 - 11/2018
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 11/2018 - 04/2009
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2017 - 09/2008
2	Autoimmune Diseases (Autoimmune Disease) 01/2013 - 10/2012
2	Proliferative Vitreoretinopathy 03/2011 - 10/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/2007 - 01/2005
2	Cholesteatoma 04/2007 - 04/2006
2	Glioblastoma (Glioblastoma Multiforme) 09/2005 - 07/2002
2	Squamous Cell Neoplasms (Squamous Cell Cancer) 08/2005 - 10/2004
2	Lung Neoplasms (Lung Cancer) 01/2005 - 01/2004
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2005 - 01/2002
1	Intervertebral Disc Degeneration 10/2019
1	Arthritis (Polyarthritis) 10/2019
1	Demyelinating Diseases (Demyelinating Disease) 11/2018

Drug/Important Bio-Agent (IBA)

51	Galectins (Galectin)IBA 02/2022 - 01/2002
44	LectinsIBA 01/2021 - 01/2002
41	Galectin 1 (LGALS1)IBA 01/2021 - 01/2002
37	Galectin 3 (LGALS3)IBA 11/2018 - 01/2002
22	Polysaccharides (Glycans)IBA 12/2021 - 01/2003
15	Proteins (Proteins, Gene)FDA Link 12/2021 - 01/2002
15	CarbohydratesIBA 07/2015 - 05/2002
11	LigandsIBA 07/2015 - 05/2002
10	Biological ProductsIBA 12/2012 - 01/2002
9	Galectin 4 (LGALS4)IBA 02/2022 - 04/2003
8	Macrophage Migration-Inhibitory FactorsIBA 08/2014 - 05/2003
7	Biomarkers (Surrogate Marker)IBA 08/2014 - 01/2003
7	Glycoproteins (Glycoprotein)IBA 04/2012 - 01/2004
6	1-nitrohydroxyphenyl-N-benzoylalanine (GAL 1)IBA 03/2018 - 01/2003
6	G(M1) GangliosideIBA 02/2016 - 03/2005
5	Carrier Proteins (Binding Protein)IBA 01/2018 - 11/2004
5	EpitopesIBA 12/2010 - 12/2002
4	GangliosidesIBA 01/2018 - 09/2003
4	MucinsIBA 02/2016 - 05/2010
4	Peptides (Polypeptides)IBA 07/2015 - 01/2004
4	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2013 - 07/2007
4	Plant LectinsIBA 08/2012 - 07/2007
3	ChemokinesIBA 12/2021 - 12/2012
3	Lactose FDA LinkGeneric 01/2020 - 09/2009
3	Keratin-19 (Keratin 19)IBA 10/2017 - 12/2002
3	AntibodiesIBA 07/2014 - 01/2002
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 11/2012 - 12/2002
3	IntegrinsIBA 04/2012 - 04/2005
3	AntigensIBA 03/2010 - 06/2003
3	Nuclear Proteins (Protein, Nuclear)IBA 09/2007 - 08/2005
3	Budesonide (Pulmicort)FDA LinkGeneric 07/2004 - 02/2002
2	Angiogenesis InhibitorsIBA 01/2021 - 08/2014
2	CollagenIBA 01/2021 - 04/2005
2	A-factor (Streptomyces)IBA 01/2021 - 07/2008
2	ProteomeIBA 01/2019 - 12/2016
2	Neuraminidase (Sialidase)IBA 01/2018 - 09/2003
2	GlycoconjugatesIBA 02/2017 - 08/2004
2	SolutionsIBA 03/2016 - 01/2004
2	GlycopeptidesIBA 07/2015 - 12/2014
2	Thomsen-Friedenreich antigenIBA 07/2015 - 12/2014
2	Pharmaceutical PreparationsIBA 05/2013 - 06/2004
2	Keratins (Keratin)IBA 02/2013 - 04/2006
2	Retinal Pigments (Pigments, Visual)IBA 03/2011 - 10/2009
2	Fibronectins (Fibronectin)IBA 03/2011 - 01/2011
2	RicinIBA 01/2009 - 07/2008
2	asialofetuinIBA 07/2008 - 04/2008
2	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 04/2007 - 01/2003
2	OligosaccharidesIBA 08/2006 - 06/2003
2	Diethylstilbestrol (Stilbestrol)FDA Link 07/2006 - 01/2005
2	Indicators and Reagents (Reagents)IBA 04/2005 - 10/2004
2	SelectinsIBA 06/2003 - 12/2002
1	VaccinesIBA 01/2021
1	calix(4)areneIBA 01/2021
1	Growth InhibitorsIBA 01/2019
1	CuprizoneIBA 11/2018
1	TenascinIBA 03/2018
1	Iodide Peroxidase (Deiodinase)IBA 10/2017

Therapy/Procedure

4	Therapeutics 01/2018 - 08/2004
2	Drug Therapy (Chemotherapy) 05/2013 - 07/2006
1	Immunotherapy 01/2020